SUO 2017

Viewing 1-20 of 174 articles

SUO 2017: Identifying The Rate And Risks Of Chronic Kidney Disease Development After Cytoreductive Nephrectomy

SUO 2017: Cost Effective Analysis of Neoadjuvant Chemotherapy Prior to Radical Cystectomy in T2 Bladder Cancer

SUO 2017: A Nationwide Analysis of Complete Urinary Tract Extirpation

SUO 2017: Hospital Volume and Short-Term Outcomes after Cytoreductive Nephrectomy

SUO 2017: Cytoreductive Nephrectomy In Patients With Metastatic Renal Cell Carcinoma And Tumor Thrombus – Trends And Effect On Overall Survival

SUO 2017: Perioperative Outcomes of Aspirin Use in Partial Nephrectomy

SUO 2017: Renal Medullary Carcinoma and Collecting Duct Carcinoma of the Kidney

SUO 2017: Comparing Effective Treatment Strategies for Squamous Cell Carcinoma of the Bladder

SUO 2017: Validation of The Preoperative Nomogram Predicting 12-Year Probability of Metastatic Renal Cancer

SUO 2017: Keynote-564: Phase 3, Double-blind, Placebo-controlled Trial Of Pembrolizumab As Adjuvant Treatment For Renal Cell Carcinoma

SUO 2017: Sarcomatoid Differentiation in Renal Cell Carcinoma: Does Stage Make A Meaningful Difference On Survival?

SUO 2017: MRI Fusion Biopsy is Associated with a Higher Rate of Pathologic Downgrading at Radical Prostatectomy

SUO 2017: Outcomes of Serial MRI/Ultrasound Fusion Targeted Biopsy

SUO 2017: The Role of Inguinal Lymph Node Dissection in Men with Urethral Squamous Cell Carcinoma

SUO 2017: The REASSURE ME Trial

SUO 2017: Surgical And Imaging Findings Of Neoadjuvant Enzalutamide And Androgen Deprivation Therapy For High Risk Prostate Cancer: An Initial Case Study For An Ongoing Clinical Trial

SUO 2017: Longitudinal Assessment Of Health-related Quality Of Life And Decisional Regret In Men With Localized Prostate Cancer

SUO 2017: Mutations And Gene Expression Differences Between African Americans And Non-African Americans With Urothelial Cell Carcinoma

SUO 2017: Oncologic Outcomes Comparing Open and Robot-Assisted Laparoscopic Radical Cystectomy for Bladder Cancer

SUO 2017: Primary Focal Cryoablation For Low-, Intermediate- And High-risk Prostate Cancer

1
2
3
4
5
6
7
8
9